A Study of the Safety and Efficacy of the Combination of Gemcitabine and Docetaxel in Metastatic Soft Tissue Sarcoma
Phase of Trial: Phase II
Latest Information Update: 02 Dec 2016
At a glance
- Drugs Ontuxizumab (Primary) ; Docetaxel; Gemcitabine
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- Acronyms SOURCE
- Sponsors Morphotek
- 28 Sep 2016 Status changed from active, no longer recruiting to completed.
- 28 Apr 2016 Planned End Date changed from 1 Apr 2016 to 1 May 2016.
- 15 Apr 2016 Planned End Date changed from 1 Mar 2016 to 1 Apr 2016.